Literature DB >> 11099445

Brain iron deposition in Parkinson's disease imaged using the PRIME magnetic resonance sequence.

J M Graham1, M N Paley, R A Grünewald, N Hoggard, P D Griffiths.   

Abstract

Iron content of the basal ganglia was investigated in 25 patients with idiopathic Parkinson's disease and 14 matched healthy control subjects using a partially refocused interleaved multiple echo sequence on a 1.5 Tesla MRI system. R(2)* (1/T(2)*) and R(2)' (1/T(2)') relaxation rates were higher in the substantia nigra of patients with Parkinson's disease, which indicates that iron content is elevated in this region. R(2)' was lower in the putamen, indicating reduced iron levels; reduction in this region was positively correlated with disease duration. Iron-related oxidative stress may contribute to the neurodegeneration of Parkinson's disease, which may lead to alterations in the iron levels of the striatum. We describe a simple, non-invasive technique for measuring iron content.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11099445     DOI: 10.1093/brain/123.12.2423

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  78 in total

Review 1.  Iron homeostasis and the inflammatory response.

Authors:  Marianne Wessling-Resnick
Journal:  Annu Rev Nutr       Date:  2010-08-21       Impact factor: 11.848

2.  MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients.

Authors:  John C Wood; Cathleen Enriquez; Nilesh Ghugre; J Michael Tyzka; Susan Carson; Marvin D Nelson; Thomas D Coates
Journal:  Blood       Date:  2005-04-28       Impact factor: 22.113

3.  Movement disorder due to aceruloplasminemia and incorrect diagnosis of hereditary hemochromatosis.

Authors:  Alfonso Fasano; Anna Rita Bentivoglio; Cesare Colosimo
Journal:  J Neurol       Date:  2007-02-14       Impact factor: 4.849

Review 4.  Magnetic resonance imaging measurement of iron overload.

Authors:  John C Wood
Journal:  Curr Opin Hematol       Date:  2007-05       Impact factor: 3.284

5.  Volume and iron content in basal ganglia and thalamus.

Authors:  Patrice Péran; Andrea Cherubini; Giacomo Luccichenti; Gisela Hagberg; Jean-François Démonet; Olivier Rascol; Pierre Celsis; Carlo Caltagirone; Gianfranco Spalletta; Umberto Sabatini
Journal:  Hum Brain Mapp       Date:  2009-08       Impact factor: 5.038

Review 6.  Differences between conventional and nonconventional MRI techniques in Parkinson's disease.

Authors:  A Baglieri; M A Marino; R Morabito; G Di Lorenzo; P Bramanti; S Marino
Journal:  Funct Neurol       Date:  2013 Apr-May

Review 7.  Region-Specific Iron Measured by MRI as a Biomarker for Parkinson's Disease.

Authors:  Xiaojun Guan; Xiaojun Xu; Minming Zhang
Journal:  Neurosci Bull       Date:  2017-05-17       Impact factor: 5.203

8.  Susceptibility MRI captures nigral pathology in patients with parkinsonian syndromes.

Authors:  Mechelle M Lewis; Guangwei Du; Jennifer Baccon; Amanda M Snyder; Ben Murie; Felicia Cooper; Christy Stetter; Lan Kong; Christopher Sica; Richard B Mailman; James R Connor; Xuemei Huang
Journal:  Mov Disord       Date:  2018-05-14       Impact factor: 10.338

9.  Brain iron concentrations in regions of interest and relation with serum iron levels in Parkinson disease.

Authors:  Paola Costa-Mallen; Christopher Gatenby; Sally Friend; Kenneth R Maravilla; Shu-Ching Hu; Kevin C Cain; Pinky Agarwal; Yoshimi Anzai
Journal:  J Neurol Sci       Date:  2017-04-23       Impact factor: 3.181

10.  MRI estimates of brain iron concentration in normal aging: comparison of field-dependent (FDRI) and phase (SWI) methods.

Authors:  Adolf Pfefferbaum; Elfar Adalsteinsson; Torsten Rohlfing; Edith V Sullivan
Journal:  Neuroimage       Date:  2009-05-12       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.